DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0007194 | Hypertrophic Cardiomyopathy | AGK | 55750 | acylglycerol kinase | Q53H12 |
C0678222 | Breast Carcinoma | AGK | 55750 | acylglycerol kinase | Q53H12 |
C0878544 | Cardiomyopathies | AGK | 55750 | acylglycerol kinase | Q53H12 |
C0017601 | Glaucoma | AGK | 55750 | acylglycerol kinase | Q53H12 |
C0010036 | Corneal dystrophy | AGK | 55750 | acylglycerol kinase | Q53H12 |
C2931822 | Nasopharyngeal carcinoma | AGK | 55750 | acylglycerol kinase | Q53H12 |
C0027819 | Neuroblastoma | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C0376358 | Malignant neoplasm of prostate | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C1306459 | Primary malignant neoplasm | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C0677886 | Epithelial ovarian cancer | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C0678222 | Breast Carcinoma | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C1134719 | Invasive Ductal Breast Carcinoma | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C0919267 | ovarian neoplasm | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C1140680 | Malignant neoplasm of ovary | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C0006826 | Malignant Neoplasms | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C4721610 | Carcinoma, Ovarian Epithelial | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C1837461 | SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3 | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C0025202 | melanoma | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C0004936 | Mental disorders | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C1168401 | Squamous cell carcinoma of the head and neck | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C3714756 | Intellectual Disability | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C0027651 | Neoplasms | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C0600139 | Prostate carcinoma | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
C0007222 | Cardiovascular Diseases | HSD17B12 | 51144 | hydroxysteroid 17-beta dehydrogenase 12 | Q53GQ0 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024